Meglumine antimoniate

This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009)

Meglumine antimoniate

Systematic (IUPAC) name
Hydroxy-dioxostiborane; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy cat.	?
Legal status	?
Identifiers
CAS number	133-51-7 N
ATC code	P01CB01 QP51AB01
PubChem	CID 64953
ChemSpider	58479 Y
ChEMBL	CHEMBL239129 Y
NIAID ChemDB	008733
Chemical data
Formula	Variable
Mol. mass	Variable
SMILES	eMolecules & PubChem
InChI InChI=1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1 Y Key:XOGYVDXPYVPAAQ-SESJOKTNSA-M Y
N (what is this?)  (verify)

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

See also

• Meglumine

This antiinfective drug article is a stub. You can help Wikipedia by expanding it. v t e